AnaptysBio Inc
NASDAQ:ANAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AnaptysBio Inc
NASDAQ:ANAB
|
US |
|
B
|
BYD Co Ltd
DUS:BY6
|
CN |
|
F
|
Fujitsu General Ltd
SWB:29F
|
JP |
|
Geron Corp
NASDAQ:GERN
|
US |
|
ICL Group Ltd
NYSE:ICL
|
IL |
|
RHB Bank Bhd
OTC:RHBAF
|
MY |
|
Endeavour Silver Corp
TSX:EDR
|
CA |
|
Atex Resources Inc
XTSX:ATX
|
CA |
|
Ascot Resources Ltd
TSX:AOT
|
CA |
|
C
|
Compagnie de Saint Gobain SA
SIX:GOB
|
FR |
|
G
|
Green Thumb Industries Inc
XBER:R9U2
|
US |
|
Chimerix Inc
NASDAQ:CMRX
|
US |
|
E
|
Engie SA
MIL:ENGI
|
FR |
|
G
|
Gfinity PLC
XBER:3GF
|
UK |
|
S
|
Scansource Inc
SWB:SC3
|
US |
|
BTC Digital Ltd
NASDAQ:BTCT
|
CN |
|
I
|
Intralot Integrated Lottery Systems & Services SA
LSE:0KA1
|
GR |
|
C
|
Copart Inc
F:CO6
|
US |
|
R
|
Redington Ltd
BSE:532805
|
IN |
|
I
|
Intertek Group PLC
SWB:IT1
|
UK |
|
SRP Groupe SA
PAR:SRP
|
FR |
|
C
|
Costco Wholesale Corp
XHAM:CTO
|
US |
|
Amcor PLC
ASX:AMCDD
|
CH |
Bankruptcy Probability
AnaptysBio Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
AnaptysBio Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
AnaptysBio Inc
NASDAQ:ANAB
|
1.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
391.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
184.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
155.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
116.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
AnaptysBio Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, AnaptysBio Inc has total debt of 276.5m USD. This includes both short-term (0 USD) and long-term (276.5m USD) debt.
You can find a full breakdown on its Balance Sheet.
